GUTS
HEALTHCAREFractyl Health Inc
$0.74+0.04 (+5.95%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving GUTS Today?
No stock-specific AI insight has been generated for GUTS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.38$3.03
$0.74
Fundamentals
Market Cap$117M
P/E Ratio—
EPS$-1.86
Dividend Yield—
Dividend / Share—
ROE-7.4%
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding158.6M
GUTS News
21 articles- Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor ConferenceYahoo Finance·May 5, 2026
- Scalable Biotech Manufacturing Unlocks a $14B MarketBenzinga·Mar 27, 2026
- Fractyl Health, Inc. Common Stock Q4 2025 Earnings Call SummaryMoby·Mar 25, 2026
- Fractyl Health Inc (GUTS) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges ...Yahoo Finance·Mar 25, 2026
- Fractyl Health Q4 Earnings Call HighlightsMarketbeat·Mar 24, 2026
- Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business UpdatesYahoo Finance·Mar 24, 2026
- H.C. Wainwright Maintains a Buy Rating on Fractyl Health, Inc. (GUTS) with an $8 Price TargetYahoo Finance·Mar 20, 2026
- Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026Yahoo Finance·Mar 17, 2026
- Fractyl Health, Inc. (GUTS) Moves to Buy: Rationale Behind the UpgradeYahoo Finance·Mar 16, 2026
- Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight MaintenanceYahoo Finance·Feb 26, 2026
- Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerYahoo Finance·Feb 23, 2026
- Fractyl Health (GUTS) Tests Whether Revita Can Redefine Post-GLP-1 Weight Maintenance EconomicsYahoo Finance·Jan 30, 2026
- Fractyl Health Showcases 6-Month REMAIN-1 Data as Revita Curbs Post-GLP-1 Weight RegainMarketbeat·Jan 29, 2026
- BC-Most Active StocksYahoo Finance·Jan 29, 2026
- Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 DiscontinuationYahoo Finance·Jan 29, 2026
- Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage PreparednessYahoo Finance·Jan 6, 2026
- Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic CategoryYahoo Finance·Jan 5, 2026
- Analysts Keep Buy Ratings on Fractyl Health (GUTS)Yahoo Finance·Jan 3, 2026
- Fractyl Health’s REVEAL-1 Study Shows Positive Six-Month Results for Revita in Maintaining Weight and Glycemic Control Post-GLP-1 UseYahoo Finance·Dec 31, 2025
- With 58% institutional ownership, Fractyl Health, Inc. (NASDAQ:GUTS) is a favorite amongst the big gunsYahoo Finance·Dec 18, 2025
- Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading MilestonesYahoo Finance·Dec 15, 2025
All 21 articles loaded
Price Data
Open$0.70
Previous Close$0.69
Day High$0.74
Day Low$0.67
52 Week High$3.03
52 Week Low$0.38
52-Week Range
$0.38$3.03
$0.74
Fundamentals
Market Cap$117M
P/E Ratio—
EPS$-1.86
Dividend Yield—
Dividend / Share—
ROE-7.4%
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding158.6M
About Fractyl Health Inc
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company is headquartered in Lexington, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—